Feed excerpt — reported by Ars Technica
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Ars Technica →